CME Group Inc. $CME Shares Purchased by World Equity Group Inc.

Posted by George Bondi on Jul 19th, 2026

World Equity Group Inc. grew its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 446.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,974 shares of the financial services provider’s stock after buying an additional 4,063 shares during the period. World Equity Group Inc.’s holdings in CME Group were worth $1,469,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. SG Americas Securities LLC grew its position in shares of CME Group by 345.2% during the 4th quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock valued at $64,965,000 after buying an additional 184,459 shares during the last quarter. FLC Capital Advisors acquired a new stake in CME Group during the fourth quarter worth about $2,122,000. First Bank & Trust bought a new position in CME Group in the fourth quarter worth about $1,325,000. Mn Services Vermogensbeheer B.V. lifted its holdings in CME Group by 2.9% in the fourth quarter. Mn Services Vermogensbeheer B.V. now owns 140,210 shares of the financial services provider’s stock worth $38,289,000 after acquiring an additional 3,931 shares during the last quarter. Finally, MOKAN Wealth Management Inc. boosted its stake in CME Group by 138.8% in the fourth quarter. MOKAN Wealth Management Inc. now owns 7,144 shares of the financial services provider’s stock valued at $1,953,000 after acquiring an additional 4,152 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the subject of several recent research reports. Weiss Ratings lowered CME Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 13th. Deutsche Bank Aktiengesellschaft cut their price target on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Morgan Stanley reduced their price objective on CME Group from $353.00 to $324.00 and set an “overweight” rating for the company in a research report on Friday, July 10th. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective for the company in a research note on Thursday, June 18th. Finally, UBS Group dropped their target price on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research report on Monday, July 6th. Twelve equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $292.12.

View Our Latest Analysis on CME

Insiders Place Their Bets

In related news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the transaction, the insider owned 27,702 shares of the company’s stock, valued at $8,438,860.26. This represents a 17.20% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

Shares of NASDAQ:CME opened at $245.05 on Friday. The firm’s 50 day moving average is $258.54 and its two-hundred day moving average is $282.12. The firm has a market capitalization of $88.80 billion, a P/E ratio of 20.91, a PEG ratio of 3.04 and a beta of 0.25. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16.

CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the previous year, the firm posted $2.80 earnings per share. The business’s revenue was up 14.5% on a year-over-year basis. Analysts anticipate that CME Group Inc. will post 12.18 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were paid a dividend of $1.30 per share. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 2.1%. CME Group’s payout ratio is presently 44.37%.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.